DBPR108

DBPR108 · National Health Research Institutes, Taiwan

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DBPR108, covering 2014-08-28 to 2022-08-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients [Phase 3]